• Je něco špatně v tomto záznamu ?

Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways

M. Micka, V. Bryja

. 2021 ; 269 (-) : 117-135. (Pharmacology of the WNT Signaling System) [pub] -

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004716

Dishevelled (DVL) is the central signal transducer in both Wnt/β-catenin-dependent and independent signalling pathways. DVL is required to connect receptor complexes and downstream effectors. Since proximal Wnt pathway components and DVL itself are upregulated in many types of cancer, DVL represents an attractive therapeutic target in the Wnt-addicted cancers and other disorders caused by aberrant Wnt signalling. Here, we discuss progress in several approaches for the modulation of DVL function and hence inhibition of the Wnt signalling. Namely, we sum up the potential of modulation of enzymes that control post-translational modification of DVL - such as inhibition of DVL kinases or promotion of DVL ubiquitination and degradation. In addition, we discuss research directions that can take advantage of direct interaction with the protein domains essential for DVL function: the inhibition of DIX- and DEP-domain mediated polymerization and interaction of DVL PDZ domain with its ligands.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004716
003      
CZ-PrNML
005      
20220127145038.0
007      
ta
008      
220113s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/164_2021_527 $2 doi
035    __
$a (PubMed)34382124
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Micka, Miroslav $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
245    10
$a Can We Pharmacologically Target Dishevelled: The Key Signal Transducer in the Wnt Pathways / $c M. Micka, V. Bryja
520    9_
$a Dishevelled (DVL) is the central signal transducer in both Wnt/β-catenin-dependent and independent signalling pathways. DVL is required to connect receptor complexes and downstream effectors. Since proximal Wnt pathway components and DVL itself are upregulated in many types of cancer, DVL represents an attractive therapeutic target in the Wnt-addicted cancers and other disorders caused by aberrant Wnt signalling. Here, we discuss progress in several approaches for the modulation of DVL function and hence inhibition of the Wnt signalling. Namely, we sum up the potential of modulation of enzymes that control post-translational modification of DVL - such as inhibition of DVL kinases or promotion of DVL ubiquitination and degradation. In addition, we discuss research directions that can take advantage of direct interaction with the protein domains essential for DVL function: the inhibition of DIX- and DEP-domain mediated polymerization and interaction of DVL PDZ domain with its ligands.
650    _2
$a adaptorové proteiny signální transdukční $7 D048868
650    _2
$a protein dishevelled $x metabolismus $7 D000072261
650    _2
$a lidé $7 D006801
650    12
$a fosfoproteiny $x metabolismus $7 D010750
650    _2
$a měniče $7 D014159
650    12
$a signální dráha Wnt $7 D060449
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bryja, Vítězslav $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. bryja@sci.muni.cz $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic. bryja@sci.muni.cz
773    0_
$w MED00208723 $t Handbook of experimental pharmacology. Pharmacology of the WNT Signaling System $x 0171-2004 $g Roč. 269, č. - (2021), s. 117-135
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34382124 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145035 $b ABA008
999    __
$a ok $b bmc $g 1752020 $s 1155865
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 269 $c - $o Pharmacology of the WNT Signaling System $d 117-135 $e - $i 0171-2004 $m Handbook of experimental pharmacology $n Handb Exp Pharmacol $x MED00208723
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

    Možnosti archivace